Skip to content

Clinical trials

Completed Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Completed Country / region: Australia Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20042
20054
20062
20071
20092
20101
20111
20121
20132
20144
20151
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb7
Novartis Pharmaceuticals7
Pfizer3
Accenture1
Ariad Pharmaceuticals1
Australasian Leukaemia and Lymphoma Group1
Children's Oncology Group1
Medical College of Wisconsin1
National Institutes of Health Clinical Center (CC)1
PX Biosolutions1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive25
Leukemia7
Precursor Cell Lymphoblastic Leukemia-Lymphoma6
Leukemia, Myeloid, Acute3
Philadelphia Chromosome3
Blast Crisis2
Bone Marrow Diseases2
Hematologic Diseases2
Leukemia, Myeloid2
Neoplasms by Histologic Type2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.